搜尋結果
Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?
Forbes· 3 日前: DYN), a biotechnology company focused on advancing genetically driven muscle diseases ...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 日前GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 ...
Tammy Faye Starlite Revisits The Life And Music Of Nico In New York City Show
Forbes· 5 日前After leaving the Velvets following The Velvet Underground and Nico LP, the singer (born Christa Päffgen) forged an iconoclastic ...
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 2 日前Have a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology ...
Researchers refine their understanding of ice surface premelting
China Daily· 2 日前Ice surface is an important medium for a variety of natural phenomena and atmospheric reactions, which has significant effects ...
Seminar held on bringing archaeology and museology together
China Daily· 6 日前Cultural heritage experts and officials gathered in Beijing to discuss the integrated development of archaeology and museum ...